Skip to main content
TipRanks
Go Ultimate75% OFF

Spero Therapeutics (2HA) Q1 2023 Earnings Report

2 Followers

DE:2HA Q1 2023 EPS Results

Actual EPS
-EUR 0.23
Consensus EPS
-EUR 0.30
Beat/Miss
Beat by +EUR 0.08
One Year Ago EPS
-EUR 0.92

DE:2HA Q1 2023 Revenue Results

Actual Revenue
EUR 671.37K
Expected Revenue
EUR 1.15M
Beat/Miss
Missed by -EUR 478.12K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2023
Date
05/11/2023
Time
After Close
Conference Call
Thursday, May 11, 2023
DE:2HA Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q1 2023 Earnings Call Audio

DE:2HA Q1 2023 Earnings Call
0:00 / 0:00

Q1 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2HA Earnings History

DE:2HA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-0.16--0.12――
Nov 12, 20262026 (Q3)-0.43-0.69-0.12-484.62% (-0.57)
Aug 12, 20262026 (Q2)―-0.15-0.03-433.33% (-0.12)
May 13, 20262026 (Q1)―-0.12-0.2348.00% (+0.11)
Mar 26, 20262025 (Q4)-0.180.48-0.34239.47% (+0.83)
Nov 13, 20252025 (Q3)-0.23-0.12-0.2959.38% (+0.17)
Aug 12, 20252025 (Q2)-0.34-0.03-0.390.91% (+0.27)
May 13, 20252025 (Q1)-0.50-0.23-0.22-4.17% (-0.01)
Mar 27, 20252024 (Q4)-0.28-0.340.87-139.58% (-1.22)
Nov 14, 20242024 (Q3)-0.24-0.29-0.05-433.33% (-0.24)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed